Matrixyl

Cosmeceutical / Signal Peptidecommercial (cosmetic ingredient)

Also known as: Palmitoyl Pentapeptide-4, Pal-KTTKS, Matrixyl 3000

A lipopeptide used in cosmetic skincare that stimulates collagen and extracellular matrix production, often marketed as a non-invasive alternative to retinol for anti-wrinkle treatment.

Overview

Matrixyl (palmitoyl pentapeptide-4) is a synthetic signal peptide consisting of five amino acids (KTTKS) linked to a palmitic acid chain to enhance skin penetration. It was developed by Sederma (now part of Croda) and is one of the most commercially successful cosmeceutical peptides worldwide. The KTTKS sequence is a fragment of type I procollagen that acts as a matrikine — a peptide fragment released during extracellular matrix turnover that signals cells to produce new matrix components. When applied topically, Matrixyl stimulates fibroblasts to increase production of collagen types I, III, and IV, as well as fibronectin and other extracellular matrix proteins. Clinical studies have demonstrated measurable wrinkle reduction comparable to retinol but with better tolerability. Matrixyl 3000 is an enhanced version that combines palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7 for synergistic effects.

Mechanism of Action

Matrixyl acts through matrikine signaling: (1) The KTTKS sequence mimics collagen breakdown fragments, triggering a wound-repair-like response in fibroblasts; (2) Activates TGF-β signaling pathway, upregulating collagen synthesis; (3) Stimulates production of collagens I, III, IV, and glycosaminoglycans; (4) Promotes fibronectin synthesis, improving skin structural integrity; (5) The palmitoyl chain facilitates penetration through the stratum corneum lipid barrier; (6) Modulates matrix metalloproteinase (MMP) activity to balance collagen production and degradation.

Molecular Formula

C39H75N5O7

Molecular Weight

711.56 g/mol

Sequence

Pal-Lys-Thr-Thr-Lys-Ser

Dosage Protocols

Dose Range

2% concentration10% concentration

Frequency

Twice daily

Route

topical

Cycle Length

Ongoing — best results seen after 8-12 weeks of consistent use

Apply to clean skin before moisturizer. Can be combined with hyaluronic acid, vitamin C, and other peptides. Most commercial products contain 2-5%. Best applied morning and evening.

Source: Manufacturer guidelines and clinical studies

Side Effects

EffectSeverity
Mild skin irritationmild
Redness at application sitemild
Allergic contact dermatitismoderate

Pros & Cons

Clinically proven to reduce wrinkle depth and volume with consistent topical use

Excellent tolerability — far fewer side effects than retinoids or acids

Widely available in commercial skincare products at various price points

Can be combined with most other skincare actives including retinol, vitamin C, and hyaluronic acid

Results are subtle and require consistent use for 2-3 months before visible improvement

Less potent than injectable treatments (Botox, fillers) or prescription retinoids

Penetration through intact skin is limited despite the palmitoyl chain

Many commercial products contain very low concentrations that may be insufficient for efficacy

Research Studies

Legal Status

Widely available as a cosmetic ingredient. Not classified as a drug. No prescription required. Included in numerous over-the-counter skincare products globally.

Related Peptides